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Abstract
Introduction: Osteoporosis (OP) increases cartilage damage in a combined rabbit model of OP and osteoarthritis
(OA). Accordingly, we assessed whether microstructure impairment at subchondral bone aggravates cartilage
damage in this experimental model.
Methods: OP was induced in 20 female rabbits, by ovariectomy and intramuscular injections of
methylprednisolone hemisuccinate for four weeks. Ten healthy animals were used as controls. At week 7, OA was
surgically induced in left knees of all rabbits. At 22 weeks, after sacrifice, microstructure parameters were assessed
by micro-computed tomography, and osteoprotegerin (OPG), receptor activator of nuclear factor-B ligand
(RANKL), alkaline phosphatase (ALP) and metalloproteinase 9 (MMP9) protein expressions were evaluated by
Western Blot at subchondral bone. In addition, cartilage damage was estimated using the histopathological Mankin
score. Mann-Whitney and Spearman statistical tests were performed as appropriate, using SPSS software v 11.0.
Significant difference was established at P < 0.05.
Results: Subchondral bone area/tissue area, trabecular thickness and polar moment of inertia were diminished in
OPOA knees compared with control or OA knees (P < 0.05). A decrease of plate thickness, ALP expression and
OPG/RANKL ratio as well as an increased fractal dimension and MMP9 expression occurred at subchondral bone of
OA, OP and OPOA knees vs. controls (P < 0.05). In addition, the severity of cartilage damage was increased in
OPOA knees vs. controls (P < 0.05). Remarkably, good correlations were observed between structural and
remodelling parameters at subchondral bone, and furthermore, between subchondral structural parameters and
cartilage Mankin score.
Conclusions: Microstructure impairment at subchondral bone associated with an increased remodelling
aggravated cartilage damage in OA rabbits with previous OP. Our results suggest that an increased subchondral
bone resorption may account for the exacerbation of cartilage damage when early OA and OP coexist
simultaneously in same individuals.
Introduction
Osteoarthritis (OA) is a multidimensional disease that
affects all anatomical joint structures, particularly carti-
lage and subchondral bone [1,2]. In turn, osteoporosis
(OP) is a skeletal disorder characterized by a compro-
mised bone strength which substantially increases the
risk of fracture [3]. Although OP and OA are two of the
most prevalent skeletal disorders, both diseases are not
frequently present in the same patient suggesting a
mutually exclusive relationship. However, clinical studies
often provide contradictory results which do not contri-
bute to define the nature of the relationship between
these medical conditions [4,5]. Furthermore, some con-
founding variables such as race, overweight and physical
activity could explain this inverse relationship per se
[6,7]. In addition, several studies may have been biased
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by design deficiencies, no radiological confirmation for
OA diagnosis, bad patient positioning at X-ray assess-
ment and/or the presence of osteophytes [8,9]. In this
context, animal models experiencing both pathologies
without interference from other factors have become
valuable tools. Indeed, in combined models of low bone
mass and OA by destabilization, ovariectomy alone or
associated with glucocorticoid administration increased
joint damage [10,11].
OA has been mostly considered a cartilage disorder.
Nevertheless, the integrity of articular cartilage has been
proposed to depend on mechanical properties of the
underlying bone [12-14]. Several studies have recognized
specific changes in the architecture and turnover of OA
subcondral bone [15-17]. In fact, cartilage damage is fre-
quently associated with thickening of the subchondral
plate and osteophytosis during knee OA in humans
[14-16,18] and animals [19]. But besides this hyper-
trophic OA, some authors contemplate another variant,
the atrophic form, which is characterized by the lack of
osteophytes and loss of subchondral bone volume in
OA patients with hip and knee compromise [20-23].
Furthermore, the correlation between the serum levels
of both C-propeptide and collagenase of type II collagen
observed in hypertrophic OA was lost in atrophic OA,
where exists a reduced type II collagen synthesis [24].
This could contribute to the absence of osteophyte for-
mation, as well as to the increased subchondral bone
turnover in rapidly progressive hip and knee OA
[25,26]. Remarkably, the presence of subchondral bone
attrition in knee OA, defined as flattening or depression
of the osseous articular surface, is strongly associated
with subchondral bone marrow lesions (BMLs) on MRI,
In turn, BMLs reflect the presence of active remodeling
processes due to chronic overload [23]. Cartilage loss
occurred in the same knee subregions as subchondral
bone attrition [27]. Likewise, subchondral bone in OA
animal models with early stages of the disease have
shown both decreased volume and stiffness [28,29], and
increased remodelling [29]. The impact of these sub-
chondral bone changes in OA is still debated, partially
due to heterogeneity of the disease [30].
Different molecular alterations have been described to
take place in the remodelling of OA subchondral bone
[31]. In this regard, the receptor activator of nuclear fac-
tor-B ligand (RANKL) and the osteoprotegerin (OPG),
members of the RANKL/RANK/OPG pathway, are
expressed differently whether the subchondral bone is
affected or not by OA [32,33]. This pathway has been
acknowledged as a key mechanism in the regulation of
osteoclast formation or activation [34]. Although sub-
chondral bone impairment seems to play a relevant role
in OA onset and progression [31], the underlying
mechanisms remain unknown. Therefore, an improved
understanding of these mechanisms would increase our
knowledge in the contribution of subchondral bone on
cartilage damage and on its suitability as a therapeutic
target in OA.
Thus, the present study aimed to assess whether
microstructure impairment at subchondral bone may
enhance cartilage damage when OA and OP are present
simultaneously in rabbits. Furthermore, we characterize
several bone microstructural parameters and metabolic
modulators involved in subchondral remodelling as well
as their relationships in these rabbits with OA aggra-
vated by previous OP.
Materials and methods
Animals
Thirty skeletally mature female, eight-month-old (3.8 to
4.8 kg body weight), New Zealand rabbits were included
in the study (Granja Universal, Pamplona, Spain). The
animals became acclimatized after two weeks and were
housed individually in stainless-steel cages and main-
tained on a 12-h light/12-h dark cycle at room tempera-
ture. The animals had free access to water and standard
rabbit chow (Panlab, Barcelona, Spain). The guidelines
for care and use of animals were followed throughout
the study, in accordance with procedures approved by
the Institutional Review Board.
Experimental animal model
OP was induced in 20 rabbits, by ovariectomy and
intramuscular injections of methylprednisolone hemi-
succinate (1 mg/kg/day for four weeks; OP group). Ten
age- and gender-matched additional animals were used
as controls (healthy group). Surgical OA was induced in
the left knees in all rabbits through medial meniscect-
omy and anterior cruciate ligament (ACL) section seven
weeks after the beginning of the study. For ovariectomy
and experimental OA, all rabbits were anesthetized and
antibiotic prophylaxis was used according to protocol
previously described [11]. Left knees were considered as
OA (n = 10) or as OA and OP (OPOA; n = 20) and
right knees were used as OP (n = 20) or healthy con-
trols (n = 10), respectively. All animals were permitted
free cage activity after surgery. Rabbits were euthanized
by intracardiac administration of sodium pentobarbital
(50 mg/kg; Pentotal, Abbott, Madrid, Spain) 15 weeks
after knee surgery (Figure 1A). At sacrifice, samples of
articular cartilage and subchondral bone of each knee
were collected for further histological and Western Blot
analysis or microstructural studies. Serum samples were
taken for determining total alkaline phosphatase (ALP)
and tartrate-resistant alkaline phosphastase (TRAP)
activity assays at baseline and at 6, 12, 16 and 21 weeks
after the study onset. All the experiments were approved
by the local ethics committee.
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Subchondral bone microstructural study
Cylindrical biopsies of subchondral bone with the size of
9 mm in length by 4 mm in diameter were extracted
from femoral condyles with a stainless steel trepan bur
for explantation (Group Komet, Lemgo, Germany). The
trepan bur was connected to a surgical motor (KaVo
Dental GmbH, Biberach, Germany) that provided a
speed of 1,500 rpm under continuous irrigation with sal-
ine soultion. Following this, the obtained biopsies were
hydrated in saline solution and frozen at -20°C for sub-
sequent analysis.
The microarchitecture of the samples was studied
using micro-computed tomography (μCT; Skyscan 1172;
Skyscan, Aartselaar, Belgium). The X-ray source was set
at 100 kV and 100 μA, with a pixel size of 10.9 μm.
Four hundred and fifty projections were acquired over
an angular range of 180° (angular step of 0.40°). Image
slices were reconstructed using the NRecon software
(Skyscan, Aartselaar, Belgium) based on the Feldkamp
algorithm, and applying corrections for beam hardening
and ring artifacts. Registered datasets were segmented
into binary images using global thresholding methods.
The trabecular bone was extracted by drawing round
contours with CTAn software (Skyscan, Aartselaar,
Belgium) and the regions of interest selected were ana-
lyzed with the same application (see Figure 1B).
The quantitative structural two-dimensional (2D) vari-
ables determined for selected regions were: tissue area
(T.Ar), bone area (B.Ar), bone area fraction (B.Ar/T.Ar
%), trabecular thickness (Tb.Th), trabecular number (Tb.
N) and trabecular separation (Tb.Sp). Furthermore, we
assessed the thickness of the first layer of subchondral
plate by measuring the distance between the subchon-
dral bone edge and the point where the value of B.Ar/T.
Ar drops to more than 98% of its value at the bone
edge. This point would indicate the presence of sub-
chondral trabecular bone. In addition, the fractal dimen-
sion (FD) and polar moment of inertia (Ip) were
calculated for each sample. FD was measured as com-
plexity index of the bone microarchitecture [35], and
calculated using the Kolmogorov or box counting
method by the Skyscan CTAn software. For 2D calcula-
tion of FD, the cross-sectional image was divided into
an array of equal squares, and the number of squares
containing part of the bone surface is counted. This was
repeated over a range of square sizes such as 2 to 100
pixels. The number of squares containing the bone sur-
face is plotted against square length in a log-log plot,
Figure 1 Experimental design . This study evaluated the effect of increased remodelling on subchondral bone microstructure and
biomechanical-related genometrics in a combined rabbit model of osteoarthritis (OA) aggravated by previous osteoporosis (OP). (a)Experimental
scheme. OVX: ovariectomy; MPH: methylprednisolone hemysuccinate. (b)Qualitative 2D models were reconstructed from images selected of a
highly representative sample for each group (HEALTHY, OA, OP and OPOA), by using the CTAn software (Skyscan, Aartselaar, Belgium).
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and finally FD was obtained from the slope of the log-
log regression. In turn, Ip was assessed as geometric
index of bone strength to resist torsion [36]. Further-
more, the moment of inertia represents the rotational
analogue of mass for linear motion. For a point mass
(represented by an image pixel) the moment of inertia
(I) is the mass (m) times the square of perpendicular
distance (r) to the rotation axis, I = mr2.
Western Blot analysis
For OPG, RANKL, ALP and MMP9 protein expression
studies, 40 μg of total protein from tibial subchondral
bone were loaded and then resolved on 10% acrylamide-
SDS gels. After transfer to polyvinylidene difluoride
(PVDF) membranes (Millipore, Molsheim, France),
membranes were blocked in 5% skimmed milk in PBS-
Tween 20 for 1 h at room temperature, and incubated
overnight at 4°C with primary antibodies. These antibo-
dies included goat anti-OPG (R&D Systems, Abingdon,
UK) at 1/1000 dilution, rabbit anti-sRANKL (Prepotech,
Neuilly-Sur-Seine, France) at 1/500, mouse anti-ALP
(Abcam, Cambridge, UK) at 1/500, and mouse anti-
MMP9 (Calbiochem/Merck Chemicals, Nottingham,
UK) at 1/500. Later, antibody binding was detected by
enhanced chemoluminiscence using peroxidase-labelled
secondary antibodies and densitometric results were
expressed in arbitrary units (AU) normalized to Glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) levels.
Serum total ALP and TRAP activity assay
Serum ALP activity was determined by colorimetry,
using p-nitrophenyl phosphate as substrate in a glycine
buffer (glycine 50 mM; Cl2Mg 0.5 mM, pH 10.5). Serum
samples were incubated at 37°C during 60 minutes, and
then the hydrolysis reaction was stopped with NaOH
0.02N. Finally, absorbance was measured at 405 nm,
since the serum ALP activity is directly proportional to
the amount of substrate degraded. For the TRAP kinetic
assay, the method was similar but the samples were
incubated in a sodium acetate 50 mM and sodium tar-
trate 10 mM (pH 4.8) buffer and the reaction was
stopped with NaOH 0.1N.
Cartilage histology
After sacrifice, femur and tibia sections were fixed in
buffered formalin for 24 h and then decalcified for six
weeks in an ethylenediaminetetraacetic acid (EDTA)
solution (2 mM EDTA, 0.5 mM tartrate sodium potas-
sium, pH 1) for further histological evaluation.
The decalcified knee joints were cleaved in a sagital
plane along the central portion of the articular surface
of each medial femoral condyle corresponding to the
weightbearing area, before embedding in paraffin wax.
Cartilage sections (5 μm) were stained with hematoxylin
and eosin to assess cellularity and structural abnormal-
ities, and with Alcian blue to evaluate matrix abnormal-
ities. The weight-bearing area of the femoral condyle
was delimited and histopathologically assessed using the
Mankin’s grading system [37] by an experienced carti-
lage pathologist. The observer was blinded with respect
to the rabbit group, laterality and macroscopic descrip-
tion. Samples were presented to the observer in random
order. A partial score for each scale category (structure
abnormalities, cellularity, matrix staining and tidemark
integrity) was allocated, and the scores in each of these
categories were combined for every section. The evalua-
tion was performed at the weight bearing surface of the
medial femoral condyle because it shows the earliest
and most severe histological abnormalities [11,38].
Statistical analysis
Results are expressed as mean ± standard error of the
mean (SEM). Data from multiple groups were compared
using Mann-Whitney non-parametric analyses as appro-
priate. Correlations were evaluated using the Spearman
test. All statistical analyses were performed using com-
mercially available software (SPSS v 11.0, SPSS Inc, Chi-
cago, USA). Differences were considered significant
when P < 0.05.
Results
Microstructure impairment at subchondral bone
Changes in subchondral microstructure were studied 15
weeks after meniscectomy and ACL section of the knee
to induce OA in a rabbit OP model (Figure 2A). Indeed,
healthy knees showed a B.Ar/T.Ar higher than OPOA
group (P < 0.05). Moreover, B.Ar/T.Ar in OPOA knees
was decreased with respect to that in OA knees (P <
0.05). Similarly, Tb.Th in groups affected by OP or both
conditions showed a downward trend with respect to
healthy controls, however, only the combined OPOA
group showed a significant decrease (P < 0.05). Conver-
sely, Tb.Sp was increased in OP and OPOA knees with
respect to healthy group (healthy: 0.24 ± 0.01 mm; OP:
0.28 ± 0.02 mm, and OPOA: 0.31 ± 0.02 mm), yet only
OPOA significatively increased it (P < 0.05). Regarding
Tb.N, no differences were found between the healthy
and other groups (P > 0.05).
Notably, the plate thickness of subchondral bone was
diminished in OA, OP or OPOA groups when compared
with the healthy one (P < 0.05). Even more, the combined
OPOA displayed a more decreased subchondral plate
thickness than the OA group (P = 0.004), see Figure 2B.
In addition, the microarchitecture index FD was
increased in all groups vs. healthy (P < 0.05), and notably
the OPOA group presented the highest difference against
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healthy or OA groups (Figure 2C). Furthermore, the bio-
mechanical-related index Ip tended to be lower in both
OA and OP groups than healthy knees, but they did not
reach a statistical significance. However, Ip value of
OPOA group was decreased when compared to healthy
or OA groups (P < 0.05) (Figure 2C).
ALP and MMP9 protein expression at subchondral bone
Remodelling was estimated in each group by measuring
the changes in protein expression of ALP and MMP9 at
subchondral bone on week 22 (Figure 3A). Subchondral
bone formation assessed by ALP protein expression was
diminished in OA, OP and OPOA groups vs. healthy
knees (healthy: 100 ± 3 AU; OA: 90 ± 1 AU; OP: 90 ± 2
AU; and, OPOA: 75 ± 2 AU; P < 0.05 in all cases).
Furthermore, subchondral ALP expression in OPOA
group also decreased with respect to that in OA group.
In turn, subchondral bone degradation estimated by
MMP9 protein expression was highly increased in OA,
OP and OPOA groups with regard to healthy knees (P
< 0.01 in all cases). However, although there was a ten-
dency to increase, subchondral MMP9 expression in the
combined group did not show a difference with respect
to that in OA or OP groups.
Increased serum ALP and TRAP enzymatic activities
In addition, serum enzymatic activities of ALP and
TRAP were assayed in order to study the status of sys-
temic bone turnover in our experimental animals. This
analysis showed a high remodelling process in OP rab-
bits with or without OA (OP and OPOA groups), com-
pared with those non-OP rabbits (healthy and OA
groups). Indeed, an increase in both ALP and TRAP
activity was found in OP and OPOA groups at week 6
(Figure 3B). Serum ALP activity was transiently
increased until week 12 and restored to normal levels
afterward in all groups. However, serum TRAP
remained high throughout the study in OP rabbits with
or without OA. It should be noted that systemic enzy-
matic activity measurements in OP or OPOA groups
were the same since their knees come from same OP
animals whether or not they underwent surgical OA. A
similar situation occurred for healthy or OA groups that
come from same non-exposed animals to OP stimulus.
OPG/RANKL ratio at subchondral bone
To determine the changes in RANKL/RANK/OPG path-
way that occur in OA aggravated by previous OP, we have
compared subchondral bone OPG and RANKL protein
Figure 2 Microstructure parameters at subchondral bone. (a)Bone area fraction (B.Ar/T.Ar), trabecular thickness (Tb.Th), trabecular number
(Tb.N) and trabecular separation (Tb.Sp) were assessed at subchondral bone. (b)Subchondral plate thickness. (c)Biomechanical-related structural
parameters, fractal dimension (FD) and polar moment of inertia (Ip), at subchondral bone. HEALTHY (n = 7), OA (n = 7), OP (n = 8) and OPOA (n
= 8) knees. OA, osteoarthritis; OP, osteoporosis. Values are expressed as mean ± SEM; *P < 0.05 vs. HEALTHY, #P < 0.05 vs. OA.
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expression between groups by Western Blot (Figure 4).
OPG synthesis was decreased in all experimental groups
respect to healthy knees (healthy: 100 ± 6 AU; OA: 78 ± 6
AU; OP: 63 ± 5 AU, and OPOA: 69 ± 3 AU; P < 0.05 in
all cases). RANKL expression was only increased in the
OPOA group vs. healthy or OP groups (healthy: 100 ± 11
AU; OA:112 ± 8 AU; OP:93 ± 5 AU, and OPOA:135 ± 9
AU; P < 0.05). In addition, we have assessed the OPG/
RANKL ratio finding a decrease in experimental groups
when compared to healthy group. Furthermore, the com-
bined group experienced a greater reduction in this ratio
than OA group (P < 0.05).
Cartilage histopathology
The impact of previous OP upon cartilage integrity in
OA knees was estimated by using the histopathological
Mankin grading score, see Figure 5. Thus, OPOA knees
showed higher total Mankin scores than control knees
(P < 0.05). Moreover, there were also differences when
the scores obtained from OPOA knees were compared
with OA knees. Overall Mankin scores in OA knees
were higher than those in OP knees, but the differences
were not significant. However, OP knees showed higher
scores than normal healthy knees (P < 0.05), suggesting
that OP could have an aggravating detrimental effect in
the development of OA lesions.
Correlations between structural and remodelling
parameters at subchondral bone with cartilage damage
The associations between remodelling and structural
parameters or OPG/RANKL ratio at subchondral bone
were assessed in the different groups. Spearman correla-
tions analysis (Table 1) showed that B.Ar/T.Ar% was
directly associated with plate thickness and Ip at sub-
chondral bone (P < 0.05), whereas, FD was inversely
associated to the other structural parameters (P < 0.05).
In the same way, at subchondral bone, the relationships
were significant between ALP and the structural para-
meters B.Ar/T.Ar%, Ip or FD as well as between MMP9
and OPG/RANKL ratio. Moreover, there were signifi-
cant correlations between subchondral bone structural
parameters or ALP expression and cartilage damage.
Figure 3 Remodelling parameters at subchondral bone and systemic level. (a)Alkaline hosphatise (ALP) and metalloproteinase 9 (MMP9)
protein expressions at subchondral bone. At top: Densitometric analysis of ALP and MMP9 protein expressions at subchondral bone. At bottom:
representative Western Blot images of ALP and MMP9 for 40 μg of total subchondral bone protein. The number of samples assayed for ALP
expression were: HEALTHY n = 10; OA n = 8; OP n = 8 and OPOA n = 10, and for MMP9 were: n = 6 in each group. OA, osteoarthritis; OP,
osteoporosis (b)Enzymatic activity for ALP and tartrato-resistant alkaline phosphatase (TRAP) in serum from OP animals (OP and OPOA groups; n
= 8; white bars) and non-OP animals (healthy and OA groups; n = 7; black bars). OA, osteoarthritis; OP, osteoporosis. Bar represents the mean ±
SEM. *P < 0.05 vs. HEALTHY, #P < 0.05 vs. OA.
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Discussion
We have studied the alterations in the microstructure of
subchondral bone originated by an increased local bone
resorption, as well as their relevant relationships with
cartilage damage in the knees of OA rabbits with pre-
vious OP. Most of clinical studies suggest an inverse
relationship between OP and OA. However, a negative
OP effect upon articular cartilage integrity has been
described in animal models [10,39-41]. Cartilage damage
has been recognized not only by an impairment of
structural and biomechanical properties, but also by
identifying changes in matrix composition or collagen
degradation in these OP models. In this sense, our
group has reported that previous OP induces cartilage
injury in a combined rabbit model of OP and OA [11].
In the current study, the knees presenting simulta-
neously OP and OA exhibited the thinnest subchondral
plate, decreased B.Ar/TAr and Tb.Th, as well as
increased Tb.Sp. In turn, the rabbits belonging to OP
and OA groups showed a decrease in subchondral plate
thickness and only a negative tendency in B.Ar/TAr and
Tb.Th values. The decrease of subchondral plate thick-
ness in OP, OA and particularly its pronounced decline
in OPOA knees would indicate that our experimental
model exhibits a much more profound effect in sub-
chondral cortical bone than in subchondral trabecular
bone. In agreement with our results, similar findings
were observed in both murine and canine models of OA
[28,42,43]. However, a thickening of subchondral plate
was described in the guinea pig OA model by partial
meniscectomy [19] and in the ACL transection-induced
OA in rat model [44,45]. It is worth noting that sub-
chondral microstructure changes in latter models corre-
sponded to an advanced OA stage [19,44,45]. In
addition, we have performed a microstructure analysis
of the subchondral bone in a cylinder sample until 9
mm deep, thus studying not only the first cortical layer,
but also the trabecular bone beneath. Consequently, our
Figure 4 Osteoprotegerin (OPG) and receptor activator of nuclear factor-B (RANKL) protein expression at subchondral bone.
Densitometric analysis of OPG, RAKL and OPG/RANKL ratio, as well as, representative Western Blot images for OPG and RANKL are shown. To
perform this blot, 40 μg of total protein from subchondral bone was used for HEALTHY, OA, OP and OPOA groups (n = 6, each group). OA:
osteoarthritis; OP: osteoporosis. Data are displayed as arbitrary units ± SEM. *P < 0.05 vs. HEALTHY, #P < 0.05 vs. OA, &P < 0.05 vs. OP.
Figure 5 Total Mankin score of histological cartilage damage.
The assessment was carried out at the weight bearing area of
medial femoral condyle. HEALTHY (n = 7), OA (n = 7), OP (n = 8)
and OPOA (n = 8) knees. OA: osteoarthritis; OP: osteoporosis. Results
are expressed as mean ± SEM; *P < 0.05 vs. HEALTHY, #P < 0.05 vs.
OA, &P < 0.05 vs. OP.
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differences in respect to other studies could be derived
from both the stage of OA development and the sub-
chondral region of analysis.
Bone is an anisotropic material since its mechanical
properties vary in different directions. In this context,
an estimated mechanical stiffness of the trabecular bone
can be obtained by an indirect method that considers
the combination of bone volume fraction and architec-
tural anisotropy. This method, the FD analysis, assesses
the directional anisotropy of trabecular bone [46]. Other
studies have also revealed that 2D fractal analysis relates
to three-dimensional parameters such as porosity and
connectivity [35]. In this way, FD in the combined
model was increased, suggesting that subchondral bone
that supports the articular cartilage in OPOA knees is
more porous than that in other groups. Using fractal
analysis by macroradiographs, it has been described a
localized OP in large human OA joints [47,48]. On the
other hand, bone architectural efficiency to resist torsion
loads can be evaluated by the Ip, which is a relevant bio-
mechanical bone factor. Thus, the higher the Ip, the
stronger and more resistant the bone is to bearing tor-
sion loads. By contrast, lower Ip drives to less bone stiff-
ness [49]. In our study, this factor was lower in the
OPOA group respect to those in other groups, hence
suggesting a higher fragility of the subchondral bone of
OPOA knees.
Bone remodelling is a finely regulated process result-
ing in the coordinated resorption and formation of ske-
letal tissue. The increase of systemic ALP and TRAP
levels at week 6 in OP animals with and without OA
(OP and OPOA groups) confirmed the presence of a
high remodelling process during early OP stages, imme-
diately after ovariectomy and glucocorticoid administra-
tion. However, on later days, the formation/resorption
balance was oriented toward the resorption as TRAP
activity continued high in OP rabbits with or without
OA. Our results are in agreement with previous studies
that have shown increased subchondral ALP levels at 38
days after ovariectomy in rats [50]. Moreover, in our
study, OP, OA, and OPOA groups presented a lower
ALP expression at subchondral bone which reflects the
systemic turnover changes seen at week 21. In contrast,
other authors reported the enzymatic ALP activity as
invariable in OP or increased in OA [51]. These differ-
ences could be due to the late OA stage studied in
human joints [51], while ALP assays in animal models
have been performed at an early OA stage [29].
Furthermore, the negative glucocorticoid effects on
bone formation in our experimental model could be
reflected in the decrease of subchondral ALP synthesis
in OPOA knees.
MMP9 expression was further analyzed as an index of
the prominent enzymatic degradation of the extracellu-
lar matrix of subchondral bone and cartilage exerted by
the MMPs. Furthermore, the presence of subchondral
bone resorption pits composed by MMP-producing cells
derived form bone marrow has been evidenced and they
contribute to cartilage degradation [52]. Previous studies
have described an increased MMP9 protein/gene expres-
sion not only in the subchondral bone but also in
articular cartilage in both human and experimental OA
studies [45,53,54]. Accordingly, we found raised sub-
chondral MMP9 protein levels in OP, OA and OPOA
groups demonstrating a clear increase in local resorp-
tion. Furthermore, subchondral MMP9 levels may
reflect the increased serum TRAP activity seen in OP
animals with or without OA (OP and OPOA groups) at
week 21. In addition, to our knowledge, this study
shows for the first time MMP9 up-regulation in an OP
experimental model, which supports the role of this
enzyme in bone resorption during OP. Taken together,
Table 1 Associations between structural, remodelling and molecular parameters at subchondral bone, and cartilage
damage score
B.Ar/T.Ar% Sb. Th FD Ip ALP MMP9 OPG/RANKL MANKIN
B.Ar/T.Ar% 1.000
Sb. Th 0.381* 1.000
FD -0.861** -0.450* 1.000
Ip 0.963** 0.347 -0.868** 1.000
ALP 0.814** 0.453 -0.754** 0.718** 1.000
MMP9 -0.115 -0.195 0.262 -0.094 -0.311 1.000
OPG/RANKL -0.280 -0.120 0.340 -0.247 -0.054 0.500* 1.000
MANKIN -0.627** -0.626** 0.672** -0.598** -0.788** 0.460 0.341 1.000
* Correlation is significant at the 0.05 level (2-tailed).
** Correlation is significant at the 0.001 level (2-tailed).
The correlation coefficients represented in this table are obtained comparing the healthy, OA, OP and OPOA groups by Spearman bivariate analysis.
B.Ar/T.Ar%, bone area fraction; FD, fractal dimension; Ip, polar moment of inertia; MANKIN, cartilage histopathological Mankin grading scorel; MMP9,
metalloproteinase 9; OA, osteoarthritis; OP, osteoporosis; OPG/RANKL ratio, osteoprotegerin/receptor activator of nuclear factor-B ratio; Sb.Th, subchondral plate
thickness.
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all these findings indicate that OP increases OA sub-
chondral remodelling through stimulation of bone
resorption, and suggest that this detrimental effect may
be particular relevant at early OA.
Remarkably, the changes at subchondral microstruc-
ture and remodelling were supported by the results
obtained at the molecular level in this study. In fact,
the subchondral OPG/RANKL ratio was decreased in
the OA, OP and OPOA groups when compared to
controls, suggesting a clear increase in subchondral
bone resorption in all these conditions. Moreover,
OPOA showed a smaller OPG/RANKL ratio than OP
or OA alone, therefore, indicating a greater subchon-
dral bone resorption in the combined group. These
results are in line with previous studies in OP and OA.
RANKL is the principal regulator of bone resorption
by promoting OC differentiation, activity, and survival.
OPG is a decoy receptor that binds to RANKL inhibit-
ing OC formation and survival [55]. A decrease in the
OPG/RANKL ratio is involved in the development of
post-menopausal or glucorticoid-induced OP, bone
erosions of rheumatoid arthritis, and bone disease
associated with malignant and non-malignant condi-
tions [56]. A reduced OPG/RANKL ratio has been also
found in subchondral OBs [57] and chondrocytes of
OA patients [58,59]. Moreover, celecoxib increased the
OPG/RANKL ratio in human OA cartilage [59]. Inter-
estingly, a decrease in this ratio in serum of OA
patients has been related to cartilage damage [60].
Thus, the OPG/RANKL ratio plays a significant role in
OP and likely in OA.
The significant correlations between bone structural,
remodelling and molecular parameters in our animal
model indicate that alterations in systemic and local
remodelling lead to changes at the structural and bio-
mechanical level at subchondral bone in OP, OA and
particularly in OPOA group. All these changes contri-
bute to impairment in subchondral bone quality, and
make this organ not able to receive and properly distri-
bute loads from and/or to the articular cartilage. More-
over, the significant correlation between subchondral
microstructure impairment and cartilage damage
denotes that changes at subchondral bone aggravate car-
tilage damage. Although discrepancies have been raised
about subchondral changes originated by the simulta-
neous presence of OP and OA in same individuals, our
findings support a synergism of both diseases, particu-
larly when early OA stage is assessed. In addition, it is
possible that in post-traumatic OA, trabecular micro-
architecture changes are different than in primary OA.
In fact, a potential osteopenia by disuse due to
decreased load bearing has been proposed during the
early post-operative period in the canine ACL-deficient
knee [61].
Conclusions
Thus, although obvious differences exist between idio-
pathic OA in humans and our rabbit mechanical model
of the disease, the results of this work strengthen the
role of the subchondral bone as a key player in the puz-
zle of OA development [12,31,42-45]. Also, they support
our previous research [11] by demonstrating that micro-
structure impairment at subchondral bone associated
with an increased remodelling increases cartilage
damage in OA rabbits with previous OP. Precisely, in
light of these studies, our current findings suggest that
an increased subchondral bone resorption may account
for the aggravation of cartilage damage when early OA
and OP coexist simultaneously in the same individuals.
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